Tacrine

Category: Alzheimers / Dementia



Tacrine Overview

Tacrine is a centrally acting anticholinesterase and indirect cholinergic agonist (parasympathomimetic). It was the first centrally acting cholinesterase inhibitor approved for the treatment of Alzheimer's disease, and was marketed under the trade name Cognex. Tacrine was first synthesised by Adrien Albert at the University of Sydney. It also acts as a histamine N-methyltransferase inhibitor.[1] Contents 1 Clinical use 2 Adverse Effects 2.1 Overdose 3 Pharmacokinetics 4...

Read more Tacrine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tacrine

Recent Tacrine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tacrine
  • Capsule: 10mg, 20mg, 30mg, 40mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Tacrine or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA